A study found that worsening sleep quality over five years was associated with poorer mental quality of life, while increasing daytime sleepiness symptoms affected both physical and mental quality of life. Objective measures of sleep did not show a significant association with quality of life.
A study found that patients satisfied with their GERD treatment had better health-related quality of life and were more likely to be taken seriously by their physicians. The quality of patient-physician communication was also a key factor in patient satisfaction.
A recent study published in Gastroenterology found that metformin significantly reduces the risk of pancreatic cancer in type 2 diabetic patients. Researchers analyzed data from over 1,800 participants and discovered a 62% reduction in risk when metformin was used alone or in combination with other therapies.
A combination of bevacizumab and erlotinib appears to be effective in treating non-small cell lung cancer (NSCLC) in elderly patients, with four partial responses observed. The regimen is well-tolerated, with common side effects including high blood pressure, fatigue, and diarrhea.
The American Dietetic Association has released an updated position paper on food and water safety, reviewing current issues and new tools to decrease illness. The paper highlights the need for collaboration among professionals, industry and government agencies to promote education, technological innovation and research.
Researchers at NYU Langone Medical Center have discovered an altered type of microbiome dominated by Gram-negative bacteria in patients with esophagitis and Barrett's esophagus. This finding may provide a new approach to understanding the pathogenesis of reflux-related disorders.
Researchers found that patients with second primary lung cancers (SPLC) are more likely to receive surgical treatment and have localized disease at diagnosis compared to those with one primary lung cancer (OPLC). However, SPLC patients experience a 12% higher lung cancer-specific mortality rate.
A Swedish study reveals that children with at least one sibling diagnosed with pediatric obstructive sleep apnea have a significantly higher risk of developing the condition themselves. The study suggests that early diagnosis and treatment can help prevent severe consequences in children.
A new study found that low-income and education levels are associated with high added sugar intake in the US. Race/ethnicity also plays a role, with Asian-Americans having the lowest intake and Black women having the highest.
A study found that prenatal alcohol exposure and small body size at birth predict poorer sleep and higher risk of sleep disturbances in 8-year-old children. Smaller body size was associated with lower sleep efficiency, while low-weight birth was linked to clinical significant sleep disturbances.
A TGen-led research team has been awarded a $1 million grant by the Melanoma Research Alliance to identify novel melanoma risk genes. The team, led by Dr. Jeffrey Trent, aims to characterize genes influencing melanoma risk and develop targeted screening or prevention efforts.
Studies presented at the WCLC confirm that targeted therapies have improved efficacy and prolonged progression-free survival time compared to chemotherapy. Patients with EGFR mutations who received gefitinib experienced longer progression-free survival and greater objective response rates, while erlotinib showed prolonged progression-f...
A study by the American Gastroenterological Association found that metformin reduces pancreatic cancer risk in diabetics by 60%. In contrast, insulin and other therapies may increase risk. The study's results suggest metformin could be a tool for primary prevention of pancreatic cancer.
Researchers created a fly model to study Parkinson's-associated dementia, finding that sleep loss caused long-lasting cognitive impairments. Curcumin blocked this effect, restoring normal learning abilities in genetically modified flies.
Researchers at Fox Chase Cancer Center have found that lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib. The study suggests that patients who are no longer controlled by cetuximab can derive clinical benefit from erlotinib, offering an additional treatment option.